ENDV
OQB Endonovo Therapeutics, Inc.$0.0001 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.0001, and at the day’s high of $0.0001
- YTD change
- +9900.00%
- vs 20-day SMA
- +28.78%
- vs 200-day SMA
- N/A
Price ranges
Price & Performance
+0.00 (+0.00%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 50.0% away from all-time highs of $0.0002
- ENDV is up 9900% since the beginning of the year
- ENDV is up 9900% over the past 12 months
- ENDV is up 0% over the past 1 month
ENDV reads n/a: the 12-month move is +0.0%.
- Previous minute
- +$0.0000
- Last hour
- +$0.0000
- Last 5 days
- +100.00%
- vs 8-day SMA
- +98.51%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Endonovo Therapeutics, Inc. is a biotechnology company, which engages in the development, manufacture, and distribution of medical devices focused on the rapid healing of wounds and reduction of pain, edema, and inflammation on and in the human body. Its technology and products include Electroceuticals, EFECT Trial, and SofPulse Electroceutical Therapy. The company was founded in November 2008 and is headquartered in Woodland Hills, CA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
